Comprehensive Approaches to Asthma

Summary: Welcome to the live virtual event Comprehensive Approaches to Asthma: Evidence-Based Therapies and Population Health Strategies! Join us on November 12th, 2025, 5:00 – 7:00 PM EST for 2 hours. This continuing education program explores evidence-based strategies for asthma management with a focus on both individual and population health outcomes. Participants will review current therapeutic approaches, including SMART, MART, and anti-inflammatory reliever therapies, and discuss how early, effective treatment can reduce emergency visits, systemic steroid use, and long-term complications. The session highlights updates from the 2025 GINA guidelines and outlines how pharmacists can play a key role in optimizing therapy, improving control, and advancing community-level asthma care.

This is a live webinar requiring engagement with various learning tools such as Zoom polling. To earn CE credit, participants must attend the program in its entirety, submit their NABP e-profile ID (e-pid) number, date of birth (MMDD), and complete the event evaluation form. Partial credit will not be awarded. The Zoom Link will be sent to you by email after purchase of a ticket.

Activity Type: Knowledge

Target Audience: Accredited for Pharmacists

Learning Objectives: At the completion of this activity, the participant will be able to:

1. Describe a comprehensive and phased approach to asthma diagnosis and management that supports improved control beginning in childhood.
2. Identify strategies to reduce preventable emergency department utilization, systemic steroid use, and hospital admissions associated with uncontrolled asthma.
3. Discuss methods to improve quality of life for pediatric patients and caregivers, increase school attendance, and reduce work absenteeism due to asthma-related illness.
4. Explain how early and effective asthma management can ultimately reduce adult morbidity, including complications related to chronic airway inflammation.
5. Review the evolving role of reliever therapy in asthma management, including SMART, MART, and anti-inflammatory reliever therapy approaches.
6. Discuss updates in the 2025 GINA guidelines and their implications for individualized asthma management.
7. Identify opportunities for pharmacists to optimize therapy and improve outcomes in patients with uncontrolled asthma

UAN: 0584-0000-25-053-L01-P

St. John Fisher University Wegmans School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.